Created in 2005 (Ireland), EQUASYM Methylphenidate Hydrochloride Modified Release Capsules own 440 sister brands and 4958 competing brands. The EQUASYM Methylphenidate Hydrochloride Modified Release Capsules brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. EQUASYM Methylphenidate Hydrochloride Modified Release Capsules is part of the Drug Manufacturers activity sector.
Share price and profitability of the share Takeda Pharmaceutical (EQUASYM Methylphenidate Hydrochloride Modified Release Capsules)
Buy Takeda Pharmaceutical share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Takeda Pharmaceutical
(EQUASYM Methylphenidate Hydrochloride Modified Release Capsules)
over 5 years*
EUR 18.10
Stock market history Takeda Pharmaceutical (EQUASYM Methylphenidate Hydrochloride Modified Release Capsules)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
